Pancreatic β-cell dysfunction contributes to type 2 diabetes mellitus (T2DM) pathogenesis. However, human islet studies have revealed few consistent molecular changes in T2DM, owing partly to technical and biological confounding factors. A new multi-omics study of islets from well-phenotyped living donors attempts to overcome these limitations to catalogue T2DM-associated molecular changes
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Aims/hypothesis Pancreatic islet beta cell failure causes type 2 diabetes in humans. To identify tra...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Most research on human pancreatic islets is conducted on samples obtained from normoglycaemic or dis...
Wigger, Barovic and Brunner et al. perform a multidimensional analysis of islets from metabolically ...
Most research on human pancreatic islets is conducted on samples obtained from normoglycaemic or dis...
Diabetes mellitus is a metabolic disease characterised by relative or absolute pancreatic β cell dys...
Most research on human pancreatic islets is conducted on samples obtained from normoglycaemic or dis...
Most research on human pancreatic islets is conducted on samples obtained from normoglycaemic or dis...
Diabetes mellitus is a metabolic disease characterised by relative or absolute pancreatic β cell dys...
Pancreatic β cell failure is central in the pathogenesis of type 2 diabetes (T2D), but the mechanism...
Although several molecular pathways have been linked to type 2 diabetes (T2D) pathogenesis, it is un...
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic β-cells. To identi...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Aims/hypothesis Pancreatic islet beta cell failure causes type 2 diabetes in humans. To identify tra...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Most research on human pancreatic islets is conducted on samples obtained from normoglycaemic or dis...
Wigger, Barovic and Brunner et al. perform a multidimensional analysis of islets from metabolically ...
Most research on human pancreatic islets is conducted on samples obtained from normoglycaemic or dis...
Diabetes mellitus is a metabolic disease characterised by relative or absolute pancreatic β cell dys...
Most research on human pancreatic islets is conducted on samples obtained from normoglycaemic or dis...
Most research on human pancreatic islets is conducted on samples obtained from normoglycaemic or dis...
Diabetes mellitus is a metabolic disease characterised by relative or absolute pancreatic β cell dys...
Pancreatic β cell failure is central in the pathogenesis of type 2 diabetes (T2D), but the mechanism...
Although several molecular pathways have been linked to type 2 diabetes (T2D) pathogenesis, it is un...
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic β-cells. To identi...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Aims/hypothesis Pancreatic islet beta cell failure causes type 2 diabetes in humans. To identify tra...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...